Insider Transactions in Q1 2023 at Rhythm Pharmaceuticals, Inc. (RYTM)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2023
|
William T. Roberts Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
912
-10.38%
|
$15,504
$17.5 P/Share
|
|
Mar 29
2023
|
William T. Roberts Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+22.16%
|
-
|
|
Mar 02
2023
|
Edward T Mathers |
BUY
Other acquisition or disposition
|
Indirect |
5,771
+50.0%
|
-
|
|
Feb 14
2023
|
Yann Mazabraud EVP, Head of International |
SELL
Open market or private sale
|
Direct |
1,177
-23.52%
|
$31,779
$27.03 P/Share
|
|
Feb 14
2023
|
Hunter C Smith Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
702
-1.17%
|
$18,252
$26.87 P/Share
|
|
Feb 14
2023
|
Jennifer Chien EVP, Head of North America |
SELL
Open market or private sale
|
Direct |
635
-11.39%
|
$16,510
$26.87 P/Share
|
|
Feb 14
2023
|
Joseph Shulman Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
554
-12.9%
|
$14,404
$26.87 P/Share
|
|
Feb 11
2023
|
Hunter C Smith Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+3.75%
|
-
|
|
Feb 11
2023
|
Jennifer Chien EVP, Head of North America |
BUY
Exercise of conversion of derivative security
|
Direct |
2,031
+26.7%
|
-
|
|
Feb 11
2023
|
Joseph Shulman Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,563
+26.68%
|
-
|
|
Feb 11
2023
|
Yann Mazabraud EVP, Head of International |
BUY
Exercise of conversion of derivative security
|
Direct |
2,031
+28.87%
|
-
|
|
Feb 09
2023
|
Jennifer Chien EVP, Head of North America |
SELL
Open market or private sale
|
Direct |
1,192
-25.11%
|
$32,184
$27.66 P/Share
|
|
Feb 09
2023
|
Jennifer Chien EVP, Head of North America |
BUY
Exercise of conversion of derivative security
|
Direct |
3,438
+42.0%
|
-
|
|
Feb 09
2023
|
Joseph Shulman Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
921
-25.14%
|
$24,867
$27.66 P/Share
|
|
Feb 09
2023
|
Joseph Shulman Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,657
+42.04%
|
-
|
|
Feb 09
2023
|
Pamela J. Cramer Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
834
-11.94%
|
$22,518
$27.66 P/Share
|
|
Feb 09
2023
|
Pamela J. Cramer Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,344
+25.13%
|
-
|
|
Feb 09
2023
|
William T. Roberts Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
959
-13.22%
|
$25,893
$27.66 P/Share
|
|
Feb 09
2023
|
William T. Roberts Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,313
+24.18%
|
-
|
|
Feb 09
2023
|
Yann Mazabraud EVP, Head of International |
SELL
Open market or private sale
|
Direct |
1,548
-34.13%
|
$41,796
$27.66 P/Share
|
|
Feb 09
2023
|
Yann Mazabraud EVP, Head of International |
BUY
Exercise of conversion of derivative security
|
Direct |
3,438
+43.12%
|
-
|
|
Feb 09
2023
|
Hunter C Smith Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,398
-2.36%
|
$37,746
$27.66 P/Share
|
|
Feb 09
2023
|
Hunter C Smith Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,063
+6.42%
|
-
|